Expression of lactoferrin on human granulocytes: Analysis with polyclonal and monoclonal antibodies

被引:35
作者
Afeltra, A [1 ]
Caccavo, D [1 ]
Ferri, GM [1 ]
Addessi, MA [1 ]
DeRosa, FG [1 ]
Amoroso, A [1 ]
Bonomo, L [1 ]
机构
[1] UNIV BARI,DEPT MED INTERNA IMMUNOL & MALATTIE INFETT,BARI,ITALY
关键词
lactoferrin; granulocytes; cytometric analysis; monoclonal and polyclonal antilactoferrin antibodies;
D O I
10.1046/j.1365-2249.1997.4351333.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lactoferrin (LF), an iron-binding protein present in specific granules of neutrophils, is expressed on membrane after granulocyte activation. It may represent a target for anti-neutrophil cytoplasmic antibodies (ANCA) in patients affected by some immunomediated diseases. We recently produced two MoAbs, AGM 2.29 and AGM 10.14, that recognize two spatially distant epitopes of human LF. In this study we perform a cytometric analysis in order to evaluate the expression of LF on the surface of granulocytes obtained from freshly drawn blood or after purification, in both the presence and absence of stimuli. Our results demonstrate that LF is not constitutively expressed on membrane of circulating neutrophils. After priming with phorbol myristate acetate (PMA) or tumour necrosis factor-alpha (TNF-alpha), an increased mean fluorescence intensity (MFI) was obtained on neutrophils stained with polyclonal anti-LF antibodies and with AGM 2.29. The kinetics of LF expression during activation demonstrated a progressive increase in MFI within 45 min. No increase in MFI was documented when primed granulocytes were stained with MoAb AGM 10.14, thus indicating that the epitope recognized by AGM 10.14 is not exposed at the cell surface. Following membrane permeabilization, performed in order to analyse the binding of anti-LF MoAbs to cytoplasmic LF, a marked increase in MFI was obtained by staining granulocytes with both anti-LF MoAbs. Indirect immunofluorescence (IIF) analysis confirmed that AGM 2.29 and AGM 10.14 reacted with human granulocytes, showing a cytoplasmic pattern on formalin-acetone-fixed neutrophils and a perinuclear one on ethanol-fixed cells.
引用
收藏
页码:279 / 285
页数:7
相关论文
共 25 条
[1]   INDUCTION OF LOW-DENSITY AND UP-REGULATION OF CD11B EXPRESSION OF NEUTROPHILS AND EOSINOPHILS BY DEXTRAN SEDIMENTATION AND CENTRIFUGATION [J].
BERENDS, C ;
DIJKHUIZEN, B ;
DEMONCHY, JGR ;
GERRITSEN, J ;
KAUFFMAN, HF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 167 (1-2) :183-193
[2]   LACTOFERRIN - A MULTIFUNCTIONAL IMMUNOREGULATORY PROTEIN [J].
BROCK, J .
IMMUNOLOGY TODAY, 1995, 16 (09) :417-419
[3]   Two spatially distant epitopes of human lactoferrin [J].
Caccavo, D ;
Afeltra, A ;
Guido, F ;
DiMonaco, C ;
Ferri, GM ;
Amoroso, A ;
Vaccaro, F ;
Bonomo, L .
HYBRIDOMA, 1996, 15 (04) :263-269
[4]   ANTILACTOFERRIN ANTIBODIES IN PATIENTS WITH RHEUMATOID-ARTHRITIS ARE ASSOCIATED WITH VASCULITIS [J].
COREMANS, IEM ;
HAGEN, EC ;
DAHA, MR ;
VANDERWOUDE, FJ ;
VANDERVOORT, EAM ;
KLEIJBURGVANDERKEUR, C ;
BREEDVELD, FC .
ARTHRITIS AND RHEUMATISM, 1992, 35 (12) :1466-1475
[5]   DAMAGE OF THE OUTER-MEMBRANE OF ENTERIC GRAM-NEGATIVE BACTERIA BY LACTOFERRIN AND TRANSFERRIN [J].
ELLISON, RT ;
GIEHL, TJ ;
LAFORCE, FM .
INFECTION AND IMMUNITY, 1988, 56 (11) :2774-2781
[6]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES INDUCE NEUTROPHILS TO DEGRANULATE AND PRODUCE OXYGEN RADICALS INVITRO [J].
FALK, RJ ;
TERRELL, RS ;
CHARLES, LA ;
JENNETTE, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4115-4119
[7]   ANTI-NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH SPECIFICITY FOR MYELOPEROXIDASE IN PATIENTS WITH SYSTEMIC VASCULITIS AND IDIOPATHIC NECROTIZING AND CRESCENTIC GLOMERULONEPHRITIS [J].
FALK, RJ ;
JENNETTE, JC .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (25) :1651-1657
[8]   NEUTROPHIL ACTIVATION DURING CELL-SEPARATION PROCEDURES [J].
JACKSON, MH ;
MILLAR, AM ;
DAWES, J ;
BELL, D .
NUCLEAR MEDICINE COMMUNICATIONS, 1989, 10 (12) :901-904
[9]   ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES - A STILL-GROWING CLASS OF AUTOANTIBODIES IN INFLAMMATORY DISORDERS [J].
KALLENBERG, CGM ;
MULDER, AHL ;
TERVAERT, JWC .
AMERICAN JOURNAL OF MEDICINE, 1992, 93 (06) :675-682
[10]  
KEOGAN MT, 1992, CLIN EXP IMMUNOL, V90, P228